Treatment of uremic mice with the combination of 25(OH)D3 + paricalcitol resulted in PTH over-suppression, hypercalcemia and hyperphosphatemia, commonly occurring with excessive vitamin D therapy in advanced human CKD stages. This evidence concerns the gene PTH and hypercalcemia disease.